Clinical Trial Update: Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis

View source ↗

Summary

A completed trial evaluated the use of SeptiFast multiplex PCR to identify the cause of sepsis in patients with hematologic diseases and to guide therapy. The r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Sepsis

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Hematologic Diseases, Sepsis | Status: COMPLETED